Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine
Open accessAbstract
Klebsiella pneumoniae is an opportunistic pathogen that is often difficult to treat due to its multidrug resistance (MDR). We have previously shown that K. pneumoniae strains are able to “adapt” (become more resistant) to the widely used bisbiguanide antiseptic chlorhexidine. Here, we investigated the mechanisms responsible for and the phenotypic consequences of chlorhexidine adaptation, with particular reference to antibiotic cross-resistance. In five of six strains, adaptation to chlorhexidine also led to resistance to the last-resort antibiotic colistin. Here, we show that chlorhexidine adaptation is associated with mutations in the two-component regulator phoPQ and a putative Tet repressor gene ( smvR ) adjacent to the major facilitator superfamily (MFS) efflux pump gene, smvA . Upregulation of smvA (10- to 27-fold) was confirmed in smvR mutant strains, and this effect and the associated phenotype were suppressed when a wild-type copy of smvR was introduced on plasmid pACYC. Upregulation of phoPQ (5- to 15-fold) and phoPQ -regulated genes, pmrD (6- to 19-fold) and pmrK (18- to 64-fold), was confirmed in phoPQ mutant strains. In contrast, adaptation of K. pneumoniae to colistin did not result in increased chlorhexidine resistance despite the presence of mutations in phoQ and elevated phoPQ , pmrD , and pmrK transcript levels. Insertion of a plasmid containing phoPQ from chlorhexidine-adapted strains into wild-type K. pneumoniae resulted in elevated expression levels of phoPQ , pmrD , and pmrK and increased resistance to colistin, but not chlorhexidine. The potential risk of colistin resistance emerging in K. pneumoniae as a consequence of exposure to chlorhexidine has important clinical implications for infection prevention procedures.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AMR has become one of the major threats to human health, emerging and spreading particularly in hospital environments as a result of selective pressures exerted by the widespread use of disinfectants and antibiotics.
“Indeed, AMR has become one of the major threats to human health, emerging and spreading, particularly in hospital environments, as a result of the selective pressures exerted by the widespread use of disinfectants and antibiotics in these settings [16].”
From Profiling the resistome and virulome of Bacillus strains used for probiotic-based sanitation: a multicenter WGS analysis (2025) · cites this paper as [16]
The introduction (page unavailable) describes multidrug-resistant pathogens as a significant health-care challenge and says disinfectants are commonly used in clinical practice. The Discussion (page unavailable) reports that chlorhexidine exposure can produce colistin cross-resistance in clinical K. pneumoniae isolates and notes their increasing prevalence in hospitals. It does not establish the broader claim that widespread disinfectant and antibiotic use drives the emergence and spread of AMR in hospitals generally. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548 · see citing works
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · see citing works
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M. V., Kulikov, A. S., Lesin, V. M., Nikolenko, S., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,691 · see citing works
Antiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell, G. E., & Russell, A. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.147 · Cited by 4,795 · see citing works
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update
Afgan, E., Baker, D., van den Beek, M., Blankenberg, D. J., Bouvier, D., Čech, M., Chilton, J. M., Clements, D., Coraor, N., Eberhard, C., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw343 · Cited by 2,150 · see citing works
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639 · see citing works
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,403 · see citing works
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,336 · see citing works
Cationic antiseptics: diversity of action under a common epithet
Gilbert, P., & Moore, L. E. (2005) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2005.02664.x · Cited by 1,168 · see citing works
Levin, B. R., Perrot, V., & Walker, N. (2000) · Genetics · doi:10.1093/genetics/154.3.985 · Cited by 636 · see citing works
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 562 · see citing works
Gunn, J. S., & Miller, S. I. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.23.6857-6864.1996 · Cited by 401 · see citing works
Falagas, M. E., Lourida, P., Poulikakos, P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01222-13 · Cited by 351 · see citing works
A novel DNA-binding motif in MarA: The first structure for an AraC family transcriptional activator
Rhee, S., Martin, R. G., Rosner, J. L., & Davies, D. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10413 · Cited by 299 · see citing works
Olaitan, A. O., Diene, S. M., Kempf, M., Berrazeg, M., Bakour, S., Gupta, S. K., Thongmalayvong, B., Akkhavong, K., Somphavong, S., Paboriboune, P., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.020 · Cited by 292 · see citing works
Regulation of polymyxin resistance and adaptation to low-Mg2+ environments
Groisman, E. A., Kayser, J., & Soncini, F. C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.22.7040-7045.1997 · Cited by 283 · see citing works
Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge
Nordmann, P. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.11.007 · Cited by 280 · see citing works
Carbapenemase-Producing Enterobacteriaceae
Paterson, D. L., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257 · see citing works
Modeling Klebsiella pneumoniae Pathogenesis by Infection of the Wax Moth Galleria mellonella
Insua, J. L., Llobet, E., Moranta, D., et al. (2013) · Infection and Immunity · doi:10.1128/iai.00391-13 · Cited by 234 · see citing works
Wright, M. S., Suzuki, Y., Jones, M. B., Marshall, S. H., Rudin, S. D., van Duin, D., Kaye, K. S., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04037-14 · Cited by 217 · see citing works
Jayol, A., Nordmann, P., Brink, A. J., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05055-14 · Cited by 202 · see citing works
Grkovic, S., Brown, M. H., Roberts, N., Paulsen, I. T., & Skurray, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18665 · Cited by 187 · see citing works
Hayden, M. K., Lin, M. Y., Lolans, K., Weiner, S., Blom, D. W., Moore, N. M., Fogg, L., Henry, D., Lyles, R. D., Thurlow, C., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1173 · Cited by 184 · see citing works
Hugo, W. B., & Longworth, A. R. (1966) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1966.tb07935.x · Cited by 183 · see citing works
Cheng, H.-Y., Chen, Y., & Peng, H. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-60 · Cited by 166 · see citing works
The mode of action of chlorhexidine
Davies, A. (1973) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1973.tb02167.x · Cited by 166 · see citing works
PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane
Dalebroux, Z. D., Matamouros, S., Whittington, D., Bishop, R. E., & Miller, S. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316901111 · Cited by 162 · see citing works
The application of Tet repressor in prokaryotic gene regulation and expression
Bertram, R., & Hillen, W. (2008) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2007.00001.x · Cited by 160 · see citing works
Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure
Webber, M. A., Whitehead, R. N., Mount, M., Loman, N. J., Pallen, M. J., & Piddock, L. J. V. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv109 · Cited by 155 · see citing works
Wand, M. E., Müller, C., Titball, R. W., et al. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-11 · Cited by 133 · see citing works
Self-citation[Antiseptics and disinfectants].
Garzón Martínez, P. (1987) · PubMed · Cited by 133 · see citing works
Ni, W., Li, Y., Guan, J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00248-16 · Cited by 129 · see citing works
NemR Is a Bleach-sensing Transcription Factor
Gray, M. J., Wholey, W.-Y., Parker, B. W., Kim, M., & Jakob, U. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454421 · Cited by 114 · see citing works
Choi, M., & Ko, K. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00952-15 · Cited by 113 · see citing works
Rubin, E. J., Herrera, C. M., Crofts, A. A., & Trent, M. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05052-14 · Cited by 112 · see citing works
Deciphering tissue-induced Klebsiella pneumoniae lipid A structure
Llobet, E., Martínez-Moliner, V., Moranta, D., Dahlström, K. M., Regueiro, V., Tomás, A., Cano, V., Pérez-Gutiérrez, C., Frank, C. G., Fernández‐Carrasco, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508820112 · Cited by 107 · see citing works
Outbreak of Klebsiella pneumoniae carbapenemase–producing K pneumoniae: A systematic review
Campos, A. C., Albiero, J., Ecker, A. B. D. S., Kuroda, C. M., Meirelles, L. E. D. F., Polato, A., Tognim, M. C. B., Wingeter, M. A., & Teixeira, J. J. V. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2016.03.022 · Cited by 96 · see citing works
Molecular analysis and nucleotide sequence of the envCD operon of Escherichia coli
Klein, J. R., Henrich, B., & Plapp, R. (1991) · Molecular and General Genetics MGG · doi:10.1007/bf00290673 · Cited by 85 · see citing works
Santiviago, C. A., Fuentes, J. A., Bueno, S. M., Trombert, A. N., Hildago, A. A., Socias, L. T., Youderian, P. A., & Mora, G. C. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03204.x · Cited by 80 · see citing works
Wand, M. E., Baker, K. S., Benthall, G., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05009-14 · Cited by 74 · see citing works
Self-citationChiang, W., Pamp, S. J., Nilsson, M., et al. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00929.x · Cited by 71 · see citing works
Gellatly, S. L., Needham, B. D., Madera, L., Trent, M. S., & Hancock, R. E. W. (2012) · Infection and Immunity · doi:10.1128/iai.00382-12 · Cited by 70 · see citing works
Bock, L. J., Wand, M. E., & Sutton, J. M. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.12.019 · Cited by 70 · see citing works
Self-citationBenthall, G., Touzel, R. E., Hind, C. K., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.014 · Cited by 66 · see citing works
Self-citationPark, Y. K., & Ko, K. S. (2015) · The Journal of Microbiology · doi:10.1007/s12275-015-4498-5 · Cited by 64 · see citing works
Elucidating the Regulon of Multidrug Resistance Regulator RarA in Klebsiella pneumoniae
Majumdar, S. D., Veleba, M., Finn, S., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01998-12 · Cited by 63 · see citing works
Curião, T., Marchi, E., Viti, C., Oggioni, M. R., Baquero, F., Martínez, J. L., & Coque, T. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00187-15 · Cited by 59 · see citing works
Schwaiger, K., Harms, K., Bischoff, M., Preikschat, P., Mölle, G., Bauer-Unkauf, I., Lindorfer, S., Thalhammer, S., Bauer, J., & Hölzel, C. S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00088 · Cited by 59 · see citing works
Fernando, D. M., Xu, W. W., Loewen, P. C., Zhanel, G. G., & Kumar, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03074-14 · Cited by 54 · see citing works
Villagra, N. A., Hidalgo, A. A., Santiviago, C. A., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn407 · Cited by 47 · see citing works
Kim, S. Y., Choi, H. J., & Ko, K. S. (2014) · Current Microbiology · doi:10.1007/s00284-014-0549-0 · Cited by 26 · see citing works
Rico‐Pérez, G., Pezza, A., Pucciarelli, M. G., de Pedro, M. A., Soncini, F. C., & del Portillo, F. G. (2015) · Molecular Microbiology · doi:10.1111/mmi.13248 · Cited by 26 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Jutkina, J., Marathe, N. P., Flach, C.-F., & Larsson, D. G. J. (2018) · Science of The Total Environment · doi:10.1016/j.scitotenv.2017.10.312 · Cited by 355 · see citing works
Resistance Toward Chlorhexidine in Oral Bacteria – Is There Cause for Concern?
Cieplik, F., Jakubovics, N. S., Buchalla, W., Maisch, T., Hellwig, E., & Al-Ahmad, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00587 · Cited by 424 · see citing works
Co-selection for antibiotic resistance by environmental contaminants
Murray, L. M., Hayes, A., Snape, J., Kasprzyk‐Hordern, B., Gaze, W. H., & Murray, A. K. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00026-7 · Cited by 334 · see citing works
Shi, X., Xia, Y., Wei, W., & Ni, B. (2022) · Water Research · doi:10.1016/j.watres.2022.119060 · Cited by 292 · see citing works
Disinfectants and antiseptics: mechanisms of action and resistance
Maillard, J., & Pascoe, M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00958-3 · Cited by 287 · see citing works
“These include analysing the effects of biocides on membrane integrity of live cells or vesicles and liposomes through the use of microscopy, the uptake of substrates (for example, fluorescent dyes or particles) and the leakage of cellular components (for example,”
BackgroundThe Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
Ridyard, K. E., & Overhage, J. (2021) · Antibiotics · doi:10.3390/antibiotics10060650 · Cited by 273 · see citing works
“To kill bacteria, chlorhexidine targets membrane fluidity, which results in the loss of structural integrity of the membrane [96].”
BackgroundBiocidal Agents Used for Disinfection Can Enhance Antibiotic Resistance in Gram-Negative Species
Kampf, G. (2018) · Antibiotics · doi:10.3390/antibiotics7040110 · Cited by 230 · see citing works
Lepelletier, D., Maillard, J., Pozzetto, B., & Simon, A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00682-20 · Cited by 219 · see citing works
“59% when introduced into decolonization protocol in orthopedic surgery (93) ● One study found that in mupirocin-resistant MRSA, the rate of qacA/B gene was 65% and smr gene was 71% (83) ● Reports of cross-resistance to antibiotics (92) ● No significant difference in incidence of SSI between topical 2% CHG (36 [0.”
BackgroundDisinfection spreads antimicrobial resistance
Lu, J., & Guo, J. (2021) · Science · doi:10.1126/science.abg4380 · Cited by 195 · see citing works
Infectious Disease Management and Control with Povidone Iodine
Eggers, M. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00260-x · Cited by 170 · see citing works
Relationships Between Oral Microecosystem and Respiratory Diseases
Dong, J., Li, W., Wang, Q., Chen, J., Zu, Y., Zhou, X., & Guo, Q. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.718222 · Cited by 151 · see citing works
Rozman, U., Pušnik, M., Kmetec, S., Duh, D., & Turk, S. Š. (2021) · Microorganisms · doi:10.3390/microorganisms9122550 · Cited by 150 · see citing works
Food processing as a risk factor for antimicrobial resistance spread along the food chain
Alexa, E. A., Likotrafiti, E., Álvarez-Molina, A., et al. (2018) · Current Opinion in Food Science · doi:10.1016/j.cofs.2018.09.002 · Cited by 136 · see citing works
“[38] Klebsiella pneumoniae Chlorhexidine Colistin Serial inoculation (up to 6 passages) in the presence of the biocide.”
BackgroundVenter, H., Henningsen, M. L., & Neville, S. L. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160053 · Cited by 129 · see citing works
Bhardwaj, P., Hans, A., Ruikar, K., Guan, Z., & Palmer, K. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01235-17 · Cited by 118 · see citing works
“It was recently reported that 69 colistin resistance emerged in the Gram-negative pathogen Klebsiella pneumoniae after 70 exposure to CHX (23).”
BackgroundBiocide-Induced Emergence of Antibiotic Resistance in Escherichia coli
Pereira, B. M. P., Wang, X., & Tagkopoulos, I. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.640923 · Cited by 120 · see citing works
Better together– Salmonella biofilm-associated antibiotic resistance
Aleksandrowicz, A., Carolak, E., Dutkiewicz, A., Błachut, A., Waszczuk, W., & Grzymajło, K. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2229937 · Cited by 116 · see citing works
“Salmonella, it was demonstrated that chlorhexidine resulted in significantly higher transcript levels of narU (5-fold).(108) During nutritional deprivation or extremely slow growth, NarU, which is abundant in the stationary phase, confers a selection advantage.”
BackgroundAddressing the challenges in antisepsis: focus on povidone iodine
Barreto, R. T., Barrois, B., Lambert, J. R., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106064 · Cited by 110 · see citing works
Amsalu, A., Sapula, S. A., Lopes, M. D. B., Hart, B. J., Nguyen, A. H., Drigo, B., Turnidge, J. D., Leong, L. E. X., & Venter, H. (2020) · Microorganisms · doi:10.3390/microorganisms8111647 · Cited by 112 · see citing works
“Biocides are also frequently used in mass-marketed household products, which could lead to the development of resistance and have severe consequences for their clinical usefulness [75,76]”
BackgroundCaselli, E., Brusaferro, S., Coccagna, M., Arnoldo, L., Berloco, F., Antonioli, P., Tarricone, R., Pelissero, G., Nola, S., La Fauci, V., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199616 · Cited by 101 · see citing works
“Control of surface contamination has been so far approached by conventional chemical-based sanitation, which has limitations, as it cannot prevent recontamination phenomena [16–19], has an high environmental impact, and can contribute to selection of disinfectant-resistant and even antibiotic-resistant pathogens [20,…”
BackgroundMCR: modern colistin resistance
Caniaux, I., van Belkum, A., Zambardi, G., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2846-y · Cited by 98 · see citing works
Zielińska, S., Wójciak, M., Dziągwa-Becker, M., et al. (2019) · Toxins · doi:10.3390/toxins11070406 · Cited by 93 · see citing works
“An increased resistance to chlorhexidine antiseptic and cross-resistance to colistin antibiotic following exposure to chlorhexidine in Klebsiella pneumoniae is one of the most studied examples of such a phenomenon [32].”
BackgroundAntibiotic Heteroresistance in Klebsiella pneumoniae
Stojowska‐Swędrzyńska, K., Łupkowska, A., Kuczyńska‐Wiśnik, D., & Laskowska, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010449 · Cited by 82 · see citing works
D’Accolti, M., Soffritti, I., Mazzacane, S., & Caselli, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071535 · Cited by 82 · see citing works
“Selected strains can become resistant not only toward the disinfectant itself but also, more importantly, against antimicrobial drugs, as recently reported for the disinfectant chlorhexidine, capable of inducing resistance against the antibiotic colistin [25].”
BackgroundDevelopment of antiseptic adaptation and cross-adapatation in selected oral pathogens in vitro
Verspecht, T., Herrero, E. R., Khodaparast, L., Khodaparast, L., Boon, N., Bernaerts, K., Quirynen, M., & Teughels, W. (2019) · Scientific Reports · doi:10.1038/s41598-019-44822-y · Cited by 81 · see citing works
Bourrel, A. S., Poirel, L., Royer, G., Mercier-Darty, M., Vuillemin, X., Kieffer, N., Clermont, O., Denamur, É., Nordmann, P., Decousser, J., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz090 · Cited by 78 · see citing works
Mouthwash Effects on the Oral Microbiome: Are They Good, Bad, or Balanced?
Brookes, Z. L. S., Teoh, L., Cieplik, F., & Kumar, P. (2023) · International Dental Journal · doi:10.1016/j.identj.2023.08.010 · Cited by 90 · see citing works
“> Wand et al 89 showed that isolates of the opportunistic pathogen Klebsiella pneumoniae can develop resistance to chlorhexidine through sharing mechanisms that correlate with colistin resistance, the last-resort antibiotic, as well as vancomycin.”
BackgroundBacteriophages as a Potential 360-Degree Pathogen Control Strategy
D’Accolti, M., Soffritti, I., Mazzacane, S., & Caselli, E. (2021) · Microorganisms · doi:10.3390/microorganisms9020261 · Cited by 75 · see citing works
“Importantly, phages could also target MDR bacteria, which are also often resistant to disinfectants [49,100].”
BackgroundGiacometti, F., Shirzad‐Aski, H., & Ferreira, S. M. P. (2021) · Antibiotics · doi:10.3390/antibiotics10060671 · Cited by 77 · see citing works
“In contrast, LPS-related changes in phageresistant mutants may reduce the expression of OmpF, tetracycline’ uptake porin, and lead to negative consequences in pathogenic bacterial populations by increasing tetracycline resistance [131,144].”
BackgroundInfluentialAugmented dissemination of antibiotic resistance elicited by non-antibiotic factors
Zhu, S., Yang, B., Wang, Z., & Liu, Y. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115124 · Cited by 76 · see citing works
Roedel, A., Dieckmann, R., Brendebach, H., et al. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01253-19 · Cited by 75 · see citing works
Chlorhexidine Resistance or Cross-Resistance, That Is the Question
Abbood, H. M., Hijazi, K., & Gould, I. M. (2023) · Antibiotics · doi:10.3390/antibiotics12050798 · Cited by 72 · see citing works
“pneumoniae, there have been reports of cross-resistance between CHX and colistin used for the treatment of carbapenem-resistant infections [89,92].”
BackgroundBiocide Selective TolC-Independent Efflux Pumps in Enterobacteriaceae
Slipski, C. J., Zhanel, G. G., & Bay, D. C. (2017) · The Journal of Membrane Biology · doi:10.1007/s00232-017-9992-8 · Cited by 72 · see citing works
“…Enterobacteriaceae is particularly concerning, since biocide resistance has demonstrated cross-resistance to a variety of antimicrobials (Chapman 2003b; Braoudaki and Hilton 2004; Gnanadhas et al. 2013), including polymyxins (Wand et al. 2017), which may represent a last line of defense.”
BackgroundHygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings
Caselli, E. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12755 · Cited by 71 · see citing works
“tance against Colistin (Wand et al., 2017), an antibiotic considered till 2016 as a last-resort drug for treatment of infections sustained by multidrug-resistant (MDR) Gram-”
BackgroundInfluentialVijayakumar, R., Sandle, T., Al-Aboody, M. S., AlFonaisan, M. K., Alturaiki, W., Mickymaray, S., Premanathan, M., & Alsagaby, S. A. (2018) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2018.05.011 · Cited by 71 · see citing works
Temperature Stability and Effectiveness of Plasma-Activated Liquids over an 18 Months Period
Tsoukou, E., Bourke, P., & Boehm, D. (2020) · Water · doi:10.3390/w12113021 · Cited by 68 · see citing works
Colistin Resistance and Management of Drug Resistant Infections
Sharma, J., Sharma, D., Singh, A., & Kumari, S. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/4315030 · Cited by 68 · see citing works
“, colistin/polymyxins due to the emergence and rapid spread of particular strains of carbapenemase-producing bacteria [2].”
BackgroundSousa, M., Machado, I., Simões, L. C., & Simões, M. V. (2025) · Environmental Science and Ecotechnology · doi:10.1016/j.ese.2025.100557 · Cited by 69 · see citing works
“A study by Wand et al. [101] demonstrated that, when exposed to chlorhexidine, Klebsiella pneumoniae acquired cross-resistance to the antibiotic colistin.”
Sonnevend, Á., Ghazawi, A., Hashmey, R., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00418-17 · Cited by 63 · see citing works
“pneumoniae isolates, and the level of chlorhexidine nonsusceptibility did not reach the levels noted in that study (21).”
BackgroundTopical Antiseptic Formulations for Skin and Soft Tissue Infections
Hoang, T. P. N., Ghori, M. U., & Conway, B. R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040558 · Cited by 60 · see citing works
Vieira, A. P. M., Arias, L. S., Neto, F. N. D. S., et al. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.11.023 · Cited by 58 · see citing works
Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection
Brunelli, S. M., Wyck, D. B. V., Njord, L., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017080870 · Cited by 57 · see citing works
“34 per 1000 CVC-days in ClearGuard versus Liu meta-analysis, respectively), but with several advantages: (1) ClearGuard antimicrobial is confined proximally to the CVC clamp, thus being prevented from entering the bloodstream as occurs with antimicrobial lock solutions18,19; (2) ClearGuard dose is fixed, thus eliminat…”
BackgroundResultInfluentialHashemi, M., Holden, B., Coburn, J., Taylor, M., Weber, S., Hilton, B., Zaugg, A. L., McEwan, C. M., Carson, R. H., Andersen, J. L., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00210 · Cited by 57 · see citing works
“Additionally, recent studies found that various clinical isolates of Klebsiella pneumoniae, from before and after the widespread use of chlorhexidine, show a significant difference in susceptibility to the antimicrobial (Bock et al., 2016; Wand et al., 2017).”
BackgroundShein, A. M. S., Wannigama, D. L., Higgins, P. G., Hurst, C. P., Abe, S., Hongsing, P., Chantaravisoot, N., Saethang, T., Luk-in, S., Liao, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17083-5 · Cited by 57 · see citing works
Exploring the Hospital Microbiome by High-Resolution 16S rRNA Profiling
Rampelotto, P. H., Sereia, A. F. R., de Oliveira, L. F. V., & Margis, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123099 · Cited by 56 · see citing works
“In addition, disinfectants can select resistant bacterial strains against themselves and also against antibiotics [42], which has been recently reported for chlorhexidine induction of resistance against Colistin [43], an antibiotic considered, until 2016, as a last-resort drug for treatment of infections sustained by…”
BackgroundDydak, K., Junka, A., Dydak, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083996 · Cited by 56 · see citing works
Klassert, T. E., Zubiría-Barrera, C., Neubert, R., Stock, M., Schneegans, A., López, M., Driesch, D., Zakonsky, G., Gastmeier, P., Slevogt, H., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.02.032 · Cited by 52 · see citing works
Spread of mcr-1–Driven Colistin Resistance on Hospital Surfaces, Italy
Caselli, E., D’Accolti, M., Soffritti, I., Piffanelli, M., & Mazzacane, S. (2018) · Emerging infectious diseases · doi:10.3201/eid2409.171386 · Cited by 51 · see citing works
D’Accolti, M., Soffritti, I., Piffanelli, M., Bisi, M., Mazzacane, S., & Caselli, E. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s170071 · Cited by 49 · see citing works
“20,21 This last aspect, in particular, represents a highly undesirable side effect of chemical cleaning, as MDR pathogens have been constantly and rapidly growing in the recent decades and a high proportion of HAIs is currently sustained by them.”
BackgroundBock, L. J., Hind, C. K., Sutton, J. M., & Wand, M. E. (2018) · Letters in Applied Microbiology · doi:10.1111/lam.12863 · Cited by 50 · see citing works
“2016) and that this adaptation may lead to increased resistance to antibiotics (Bhardwaj et al. 2016; Buffet-Bataillon et al. 2016; Vijayakumar et al. 2016b; Wand et al. 2017).”
BackgroundSelf-citationWand, M. E., Jamshidi, S., Bock, L. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37730-0 · Cited by 50 · see citing works
Self-citationden Poel, B. V., Saegeman, V., & Schuermans, A. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-022-04403-w · Cited by 48 · see citing works
“pneumoniae isolates to CHG exposure led to an increase of MIC values for colistin from 2 to 4 mg/L to > 64 mg/L [27].”
BackgroundBiofilms as protective cocoons against biocides: from bacterial adaptation to One Health issues
Charron, R., Boulanger, M., Briandet, R., & Bridier, A. (2023) · Microbiology · doi:10.1099/mic.0.001340 · Cited by 48 · see citing works
Valentin, E., Bottomley, A. L., Chilambi, G. S., Harry, E. J., Amal, R., Sotiriou, G. A., Rice, S. A., & Gunawan, C. (2019) · Nanoscale · doi:10.1039/c9nr08424j · Cited by 48 · see citing works
Buxser, S. E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256336 · Cited by 48 · see citing works
“pneumoniae isolated in the 1940s and 1950s prior to the widespread use of antibiotics [32, 33], were compared to more recently isolated strains [34].”
ResultEger, E., Schwabe, M., Schulig, L., Hübner, N., Bohnert, J. A., Bornscheuer, U. T., Heiden, S. E., Müller, J. U., Adnan, F., Becker, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00148-22 · Cited by 48 · see citing works
“It is well known that cross-resistance (48) and collateral sensitivity (49) may accompany”
BackgroundMao, X., Hiergeist, A., Auer, D. L., Scholz, K. J., Muehler, D., Hiller, K., Maisch, T., Buchalla, W., Hellwig, E., Gessner, A., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.934525 · Cited by 47 · see citing works
“Furthermore, selection pressure due to antiseptic treatment may lead to selection of antibiotic-resistant strains (Wand et al., 2017; Verspecht et al., 2019).”
BackgroundAnforderungen an die Hygiene bei der Reinigung und Desinfektion von Flächen
KRINKO (2022) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-022-03576-1 · Cited by 48 · see citing works
Krämer, A., Lexow, F., Bludau, A., Köster, A. M., Misailovski, M., Seifert, U., Eggers, M., Rutala, W. A., Dancer, S. J., & Scheithauer, S. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00186-23 · Cited by 47 · see citing works
Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates
Richter, S. E., Miller, L. G., Uslan, D. Z., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00149-18 · Cited by 46 · see citing works
“13–15, 21, 23), prior treatment with colistin (18, 21, 23, 24), exposure to chlorhexidine (25), the presence of multiple comorbidities in the patients (21, 22), and increasing age, male sex, length of hospitalization, and the presence of indwelling urinary catheters (22).”
BackgroundIs Chlorhexidine in Dentistry an Ally or a Foe? A Narrative Review
Pałka, Ł., Nowakowska-Toporowska, A., & Dalewski, B. (2022) · Healthcare · doi:10.3390/healthcare10050764 · Cited by 46 · see citing works
“The reason for the recent increase in papers regarding this topic has been connected with the reported emergence of Gram-negative bacteria resistant to colistin, which is a last resort antibiotic after exposure to CHX [5,6].”
BackgroundThe oral microbiome, nitric oxide and exercise performance
Bryan, N. S., Burleigh, M. C., & Easton, C. (2022) · Nitric Oxide · doi:10.1016/j.niox.2022.05.004 · Cited by 46 · see citing works
Schwarz, S. R., Hirsch, S., Hiergeist, A., Kirschneck, C., Muehler, D., Hiller, K., Maisch, T., Al‐Ahmad, A., Gessner, A., Buchalla, W., et al. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03613-w · Cited by 45 · see citing works
Zhang, J., Cheng, L., Li, H., Chen, X., Zhang, L., Shan, T., Wang, J., Chen, D., Shen, J., Zhou, X., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.178020 · Cited by 44 · see citing works
Berglund, B. (2019) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000002 · Cited by 43 · see citing works
Chlorhexidine leads to the evolution of antibiotic-resistant Pseudomonas aeruginosa
TagElDein, M. A., Yassin, A. S., El‐Tayeb, O. M., & Kashef, M. T. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04292-5 · Cited by 43 · see citing works
Kampf, G. (2019) · Microbial Cell · doi:10.15698/mic2019.07.683 · Cited by 41 · see citing works
“pneumoniae 6 clinical strains with a variety of antibiotic resistance markers 6 passages of 2 days at various concentrations 4fold – 16fold 512 Stable for 10 d Cross-resistance*** to colistin (6 strains); no cross-adaptation to BAC, octenidine, hexadecylpyridinium chloride monohydrate and ethanol [16]”
BackgroundThe antiseptic Miramistin: a review of its comparative in vitro and clinical activity
Osmanov, A., Farooq, Z., Richardson, M. D., & Denning, D. W. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa012 · Cited by 42 · see citing works
“Another example is chlorhexidine cross-resistance with sulfamethoxazole, ceftazidime, tetracycline, cefotaxime, and imipenem (Braoudaki and Hilton 2004; Pumbwe, Skilbeck and Wexler 2007; Knapp et al. 2013; Wand et al. 2017).”
BackgroundD’Accolti, M., Soffritti, I., Bini, F., Mazziga, E., Mazzacane, S., & Caselli, E. (2022) · Microorganisms · doi:10.3390/microorganisms10020225 · Cited by 39 · see citing works
“Cross-resistance to antibiotics was also found with triclosan, octenidine, sodium hypochlorite, and didecyldimethylammonium chloride [3,7].”
BackgroundInfluentialPulsed UV as a potential surface sanitizer in food production processes to ensure consumer safety
Garvey, M., & Rowan, N. J. (2019) · Current Opinion in Food Science · doi:10.1016/j.cofs.2019.03.003 · Cited by 38 · see citing works
Hijazi, K., Joshi, C., & Gould, I. M. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1640602 · Cited by 45 · see citing works
“the effect of biocides on the emergence and spread of AMR [44,45].”
BackgroundSix Extensively Drug-Resistant Bacteria in an Injured Soldier, Ukraine
McGann, P., Lebreton, F., Jones, B. T., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2908.230567 · Cited by 37 · see citing works
“Colistin resistance likely resulted from a previously characterized E82K mutation in the 2-component transcriptional regulator PhoP (4).”
BackgroundLi, L., Short, F. L., Hassan, K. A., Naidu, V., Pokhrel, A., Nagy, S. S., Prity, F. T., Shah, B. S., Afrin, N., Baker, S. G., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01474-z · Cited by 37 · see citing works
Alexis Diomedi, P., Chacón, E., Delpiano, L., Hervé, B., Jemenao, M. I., Medel, M., Quintanilla, M., Gisela Riedel, M., Tinoco, J., & Cifuentes, M. (2017) · Revista chilena de infectología · doi:10.4067/s0716-10182017000200010 · Cited by 37 · see citing works
Muggeo, A., Guillard, T., Klein, F., et al. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.10.023 · Cited by 37 · see citing works
D’Accolti, M., Soffritti, I., Lanzoni, L., Bisi, M., Volta, A., Mazzacane, S., & Caselli, E. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13415 · Cited by 36 · see citing works
“Other important limitations include the high environmental impact and their potential contribution to the selection of antimicrobial resistant (AMR) strains, thus worsening the AMR concern (Bock et al., 2016; Wand et al., 2017; Fahimipour et al., 2018).”
BackgroundStone, W., Tolmay, J., Tucker, K., & Wolfaardt, G. M. (2020) · Microorganisms · doi:10.3390/microorganisms8111726 · Cited by 37 · see citing works
“Excessive and inefficient use of disinfectants, similar to excessive and inefficient use of antibiotics, may increase a hospital’s risk of becoming an incubator for resistant pathogens [6,11].”
BackgroundCason, C., D’Accolti, M., Campisciano, G., Soffritti, I., Ponis, G., Mazzacane, S., Maggiore, A., Risso, F. M., Comar, M., & Caselli, E. (2021) · Pathogens · doi:10.3390/pathogens10050615 · Cited by 36 · see citing works
Bacteriophages in Infectious Diseases and Beyond—A Narrative Review
Ιωάννου, Π., Baliou, S., & Samonis, G. (2023) · Antibiotics · doi:10.3390/antibiotics12061012 · Cited by 37 · see citing works
“In vitro tests have shown that if PCHS are combined with phages, they retain their stability and activity, allowing them to target bacteria with significant antimicrobial resistance that are often also resistant to disinfectants, thus leading to an additive or synergistic effect [104,109,116].”
BackgroundRoedel, A., Vincze, S., Projahn, M., Roesler, U. H., Robé, C., Hammerl, J. A., Noll, M., Dahouk, S. A., & Dieckmann, R. (2021) · Microorganisms · doi:10.3390/microorganisms9030651 · Cited by 34 · see citing works
“In vitro studies showed that antibiotic cross-resistance can occur during bacterial exposure to subinhibitory concentrations of biocides like QACs [92], biguanides [93], and phenolic compounds [94].”
BackgroundWand, M. E., Darby, E. M., Blair, J. M. A., et al. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001496 · Cited by 34 · see citing works
“Primers used have already been described [17] except for acrA primers (KPacrA665R3 TCATTGCTCGACTGGGTGAC; KPacrA586F3 CAGAATGGTCAAACGACCGC) and ramA primers (KPramA332R3 CGACTGTGGTTCTCTTTGCG; KP ramA 260F3 AGACCTTTACCCGCGTCTTC).”
BackgroundMethodInfluentialSelf-citationLemmen, S., & Lewalter, K. (2018) · Infection · doi:10.1007/s15010-018-1137-1 · Cited by 33 · see citing works
“Antiseptic washing Significant reduction of transmission of MRSA and VRE in ICU and BMT Significant reduction of BSI in ICU As an horizontal approach effective for sensitive pathogen, as well Time saving in comparison to washing with water and soap [40] [40, 41] [41] Concern of emergence of resistance against CHG Redu…”
Bertolotti, A., Sbidian, É., Join‐Lambert, O., et al. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19710 · Cited by 33 · see citing works
Efflux-mediated tolerance to cationic biocides, a cause for concern?
Wand, M. E., & Sutton, J. M. (2022) · Microbiology · doi:10.1099/mic.0.001263 · Cited by 35 · see citing works
Self-citationMasci, D., Hind, C. K., Islam, M. K., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.087 · Cited by 33 · see citing works
Self-citationZhang, Z., Yu, J. L., Yao, C., et al. (2020) · Dental Materials · doi:10.1016/j.dental.2020.08.009 · Cited by 32 · see citing works
Soffritti, I., D'Accolti, M., Cason, C., Lanzoni, L., Bisi, M., Volta, A., Campisciano, G., Mazzacane, S., Bini, F., Mazziga, E., et al. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s356740 · Cited by 30 · see citing works
Bleriot, I., Blasco, L., Delgado-Valverde, M., Gual-de-Torrella, A., Ambroa, A., Fernández-García, L., López, M. C., Oteo, J., Wood, T. K., Pascual, Á., et al. (2020) · Toxins · doi:10.3390/toxins12090566 · Cited by 28 · see citing works
“pneumoniae adapted to CHLX also presented resistance to colistin, increasing their MIC values from 2–4 mg/L to 64 mg/L [9].”
BackgroundInfluentialHeterogeneity and Diversity of mcr-8 Genetic Context in Chicken-Associated Klebsiella pneumoniae
Wu, B., Wang, Y., Ling, Z., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01872-20 · Cited by 30 · see citing works
“concern because of their resistance to multiple antimicrobial agents (1).”
BackgroundBeier, R. C., Byrd, J. A., Andrews, K., et al. (2020) · Poultry Science · doi:10.1016/j.psj.2020.10.045 · Cited by 30 · see citing works
“, 2016), and the use of biocides has been demonstrated to result in antimicrobial crossresistance (Maris, 1991; Sidhu et al., 2002a; Braoudaki and Hilton, 2004; Beier et al., 2005; Davin-Regli and Pag es, 2012; Al-Jailawi et al., 2013; Gnanadhas et al., 2013; Wales and Davies, 2015; Romaro et al., 2017; Wand et al., 2…”
BackgroundD’Accolti, M., Soffritti, I., Bonfante, F., Ricciardi, W., Mazzacane, S., & Caselli, E. (2021) · Viruses · doi:10.3390/v13112227 · Cited by 29 · see citing works
Priming with biocides: A pathway to antibiotic resistance?
Adkin, P., Hitchcock, A., Smith, L. J., & Walsh, S. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15564 · Cited by 23 · see citing works
Bacterial cross-resistance to anti-infective compounds. Is it a real problem?
Cândido, E. D. S., de Barros, E., Cardoso, M. H. E. S., et al. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.05.004 · Cited by 28 · see citing works
An Innovative Strategy for the Effective Reduction of MDR Pathogens from the Nosocomial Environment
Caselli, E., D’Accolti, M., Soffritti, I., Lanzoni, L., Bisi, M., Volta, A., Berloco, F., & Mazzacane, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_399 · Cited by 28 · see citing works
Garratt, I., Aranega-Bou, P., Sutton, J. M., et al. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.00210-21 · Cited by 28 · see citing works
“pneumoniae (40), and smvR mutations were first observed before secondary highlevel tolerance to octenidine in P.”
BackgroundMethodInfluentialSelf-citationAuer, D. L., Mao, X., Anderson, A. C., Muehler, D., Wittmer, A., OHLE, C. V., Wolff, D., Frese, C., Hiller, K., Maisch, T., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11050688 · Cited by 28 · see citing works
“, Klebsiella pneumoniae [9,10,58], and similar observations could be made with respect to CPC [7], phenotypic antibiotic resistance was evaluated.”
BackgroundKaspar, J. R., Godwin, M. J., Velsko, I. M., Richards, V. P., & Burne, R. A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00161-19 · Cited by 28 · see citing works
“Adaptations to 96 CHX may also lead to cross-resistance to other antimicrobials, as was noted recently with 97 clinical strains of Klebsiella pneumoniae that could acquire resistance to the last-resort antibiotic 98 colistin after exposure to CHX (21).”
BackgroundPseudomonas Phage ZCPS1 Endolysin as a Potential Therapeutic Agent
Abdelrahman, F. I., Gangakhedkar, R., Nair, G. A., El–Didamony, G., Askora, A., Jain, V. P., & El‐Shibiny, A. (2023) · Viruses · doi:10.3390/v15020520 · Cited by 27 · see citing works
“coli is resistant to triclosan [45], Klebsiella pneumoniae is resistant to colistin [46], Salmonella spp.”
BackgroundBaig, M. I. R., Kadu, P. K., Bawane, P. P., Nakhate, K. T., Yele, S., Ojha, S. K., & Goyal, S. N. (2023) · The Journal of Antibiotics · doi:10.1038/s41429-023-00649-4 · Cited by 27 · see citing works
Chen, T., Wang, Y., Chi, X., et al. (2024) · Virulence · doi:10.1080/21505594.2024.2349768 · Cited by 27 · see citing works
“Moreover, some authors report K. pneumoniae showing cross-resistance to polymyxin and chlorhexidine [46,47].”
Background
- Authors
- Wand, M. E., Bock, L. J., Bonney, L. C., & Sutton, J. M.
- Affiliations
- Public Health England (GB)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2017-01
- Volume
- 61
- Issue
- 1
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC5192135
- OpenAlex
- W2540856562
- Cited by
- 313
- References
- 54
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 23 · 2023: 34 · 2022: 46 · 2021: 43 · 2020: 36 · 2019: 47 · 2018: 19 · 2017: 18 · 2016: 3
- FWCI
- 13.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Public Health England (GIA 109506)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Chemistry › Organic Chemistry › Antimicrobial agents and applications
- Keywords
- Klebsiella pneumoniae, chlorhexidine, colistin, cross-resistance, PhoPQ two-component system, major facilitator superfamily, multidrug resistance, infection control
- MeSH terms
- Anti-Bacterial Agents, Bacterial Proteins, Chlorhexidine, Colistin, Klebsiella pneumoniae, Microbial Sensitivity Tests, Mutation, Plasmids, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review